CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics.
Understanding the risk of NMS in young patients
A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect